The development of GS-441524 and similar antivirals has transformed FIP from a death sentence to a treatable disease. Welfare management through the treatment course is now achievable.
The development of effective antiviral treatment for FIP represents one of the most dramatic welfare advances in feline medicine of the past decade. Previously, an FIP diagnosis meant certain death within days to weeks — cats with wet FIP accumulated abdominal or thoracic fluid, became progressively weaker, and died. The discovery that GS-441524 achieves remission in most cats with wet FIP has transformed thousands of cat lives from inevitable death to survival with good quality of life.
The welfare experience of treatment requires management. Daily injections cause pain at injection sites — site rotation, appropriate needle gauge, and dilution strategies reduce injection pain. The 84-day treatment duration requires exceptional owner commitment but is achievable with appropriate support. Oral GS-441524 formulations available in some markets improve welfare by eliminating injection pain while maintaining antiviral efficacy.